News

SpeeDx new US Headquarters

SpeeDx have successfully settled into new U.S. Headquarters at the Texas Health CoLab in Austin Texas. Chosen for its synergy in supporting progressive and innovative health solutions, the technology hub is the perfect location to stage the launch of ResistancePlus® MG later in the year.

“The CoLab in Austin as the perfect base for us, working alongside other like-minded innovators and health entrepreneurs,” said Colin Denver, SpeeDx CEO. “We are moving quickly towards the end of our clinical trials and are excited to be preparing for the launch of ResistancePlus MG to the US market.”